These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32553631)

  • 1. RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation.
    Luo Z; Ye X; Shou F; Cheng Y; Li F; Wang G
    Biochem Biophys Res Commun; 2020 Sep; 530(2):425-431. PubMed ID: 32553631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation.
    Luo Z; Ye X; Cheng Y; Li F; Shou F; Wang G
    Biochem Biophys Res Commun; 2021 Jun; 556():106-113. PubMed ID: 33839405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.
    Chen L; Zhang L; He H; Shao F; Yu Z; Gao Y; He J
    Oncogene; 2024 Jun; 43(26):2025-2037. PubMed ID: 38744954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
    Wang L; Meng Y; Zhang QY
    BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
    Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
    Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
    Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
    Yang G; Gong Y; Wang Q; Wang L; Zhang X
    Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
    Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
    Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells.
    Liu Z; Xu L
    BMB Rep; 2018 Dec; 51(12):642-647. PubMed ID: 30545437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM65 negatively regulates p53 through ubiquitination.
    Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
    Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma.
    Liu Y; Zhou Y; Zhang P; Li X; Duan C; Zhang C
    Cell Death Differ; 2021 Mar; 28(3):1026-1040. PubMed ID: 33082516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
    Zhao X; Wu X; Wang H; Yu H; Wang J
    Mol Carcinog; 2020 Aug; 59(8):1000-1011. PubMed ID: 32511815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
    Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
    J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
    Shen QM; Wang HY; Xu S
    Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
    Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.